Ib Jarle Christensen

Department of Gastroenterology, Hvidovre Hospital, Copenhagen University Hospital, Denmark

Disclosure: Nothing to disclose

Presentation(s):

• PATH-28 - Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients

  Friday, November 22
  7:30 PM – 9:30 PM

• EPID-13 - Identification of prognostic markers in a cohort of consecutive non-selected glioblastoma patients receiving standard therapy

  Saturday, November 23
  5:00 PM – 7:00 PM

• EPID-06 - Immune-related plasma biomarkers in glioblastoma

  Saturday, November 23
  5:08 PM – 5:12 PM